|
FDA Approves Gilead’s ‘Quad’ Combo Pill for HIV Treatment
The FDA has approved Gilead’s Stribild, previously called Quad, as a once-daily combo pill for treatment-naïve adults with HIV. Stribild (elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate) contains two previously approved drugs plus two new drugs — elvitegravir and cobicistat.
Drug Industry Daily |
Register Now
Archives